Ginkgo Bioworks Holdings, Inc. (DNA) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 5 recommend buying, 2 recommend holding, and 4 recommend selling.
The analyst consensus price target for DNA is $7.84, representing a +1.6% upside from the current price of $7.72. Price targets range from a low of $4.35 to a high of $12.00.
